CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE496.252.95 (+0.6 %)
PREV CLOSE () 493.30
OPEN PRICE () 489.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11051
TODAY'S LOW / HIGH ()486.25 499.00
52 WK LOW / HIGH ()408.95 645
NSE495.002.65 (+0.54 %)
PREV CLOSE() 492.35
OPEN PRICE () 490.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 104914
TODAY'S LOW / HIGH() 485.55 499.10
52 WK LOW / HIGH ()409 645.75
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984

Management Info :

Prakash M Patil - Chairman Rashesh C Gogri - Managing Director

Registered Office :

Address : Plot No N 198,M I D C,Tarapur Village - Patembhi, Taluka Palghar,
Thane,
Maharashtra-401506

Phone : 022-24019025

Website : www.aartidrugs.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
28Aug Aarti Drugs informs about newspaper cl
Aarti Drugs has informed that the Post Buyback Public Announcement in co..
07Jul Aarti Drugs wins Pharmexcil Outstandin
Aarti Drugs has won Pharmexcil Outstanding Exports Award 2021-2022. The..
07Jul Aarti Drugs moves up on the BSE
Aarti Drugs is currently trading at Rs. 473.55, up by 3.25 points or 0.6..
02May Aarti Drugs informs about disclosure
Aarti Drugs has informed that it is not a Large Corporate as per the app..
28Feb Aarti Drugs informs about analyst meet
Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligati..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit316.2000000000011528.1
Gross Profit 428.700000000001 2048.1
Operating Profit 614.2000000000012846.3
Net Sales 5382.124979.7
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1455.20 (10.00%)
M.Cap ( in Cr)
846.88
Solara Active Pharma (BSE)
 551.45 (16.32%)
M.Cap ( in Cr)
1985.01
Abbott India (BSE)
 26131.85 (0.29%)
M.Cap ( in Cr)
55528.36
Windlas Biotech (BSE)
 555.05 (6.97%)
M.Cap ( in Cr)
1154.42
Concord Biotech (BSE)
 1595.25 (1.05%)
M.Cap ( in Cr)
16688.90
Shareholding Pattern
PROMOTERS 57.47%
NON-INSTITUTION 35.17%
MUTUAL FUNDS/UTI 5.18%
FI/BANKS/INSURANCE 0.08%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX73088.33599.34 (0.83%)
NIFTY22147.00151.15 (0.69%)
Dow Jones 37775.3822.07 (0.06%)
Nasdaq 15601.50-81.87 (-0.52%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI